Merck KGaA Valuation
| MRK Stock | 137.85 0.35 0.25% |
At this time, the firm appears to be overvalued. Merck KGaA secures a last-minute Real Value of USD121.31 per share. The latest price of the firm is USD137.85. Our model forecasts the value of Merck KGaA from analyzing the firm fundamentals such as Return On Equity of 0.14, current valuation of 87.36 B, and Profit Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Merck KGaA's price fluctuation is very steady at this time. Calculation of the real value of Merck KGaA is based on 3 months time horizon. Increasing Merck KGaA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Merck KGaA's intrinsic value may or may not be the same as its current market price of 137.85, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 137.85 | Real 121.31 | Hype 137.85 | Naive 132.71 |
The intrinsic value of Merck KGaA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Merck KGaA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Merck KGaA helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck KGaA more accurately as focusing exclusively on Merck KGaA's fundamentals will not take into account other important factors: Merck KGaA Total Value Analysis
Merck KGaA is now forecasted to have takeover price of 87.36 B with market capitalization of 76.08 B, debt of 30.69 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Merck KGaA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.36 B | 76.08 B | 30.69 B |
Merck KGaA Investor Information
About 60.0% of the company shares are owned by institutional investors. The book value of Merck KGaA was now reported as 64.91. The company recorded earning per share (EPS) of 7.98. Merck KGaA last dividend was issued on the 25th of April 2022. The entity had 2:1 split on the 30th of June 2014. Based on the key measurements obtained from Merck KGaA's financial statements, Merck KGaA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Merck KGaA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Merck KGaA has an asset utilization ratio of 43.4 percent. This implies that the Company is making USD0.43 for each dollar of assets. An increasing asset utilization means that Merck KGaA is more efficient with each dollar of assets it utilizes for everyday operations.Merck KGaA Ownership Allocation
Merck KGaA maintains a total of 129.24 Million outstanding shares. Over half of Merck KGaA's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Merck KGaA. Please watch out for any change in the institutional holdings of Merck KGaA as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Merck KGaA Profitability Analysis
The company reported the revenue of 19.69 B. Net Income was 3.06 B with profit before overhead, payroll, taxes, and interest of 12.36 B.About Merck KGaA Valuation
The stock valuation mechanism determines Merck KGaA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Merck KGaA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merck KGaA. We calculate exposure to Merck KGaA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck KGaA's related companies.8 Steps to conduct Merck KGaA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Merck KGaA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Merck KGaA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Merck KGaA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Merck KGaA's revenue streams: Identify Merck KGaA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Merck KGaA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Merck KGaA's growth potential: Evaluate Merck KGaA's management, business model, and growth potential.
- Determine Merck KGaA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Merck KGaA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Merck Stock Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.